Cargando…

Systematic Review and Meta-Analysis on Quality of Life in Diabetic Patients in Iran

BACKGROUND: Diabetes is the fifth leading cause of death in the world, which reduces the patients' quality of life (QOL) and is considered as an important subject especially in medicine and medical community. The present study aimed at investigating the QOL of diabetic patients in Iran through...

Descripción completa

Detalles Bibliográficos
Autores principales: Fakhri, Moloud, Abdan, Mohsen, Ramezanpour, Melina, Dehkordi, Ali Hasanpour, Sarikhani, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223913/
https://www.ncbi.nlm.nih.gov/pubmed/34211672
http://dx.doi.org/10.4103/ijpvm.IJPVM_327_19
_version_ 1783711788094717952
author Fakhri, Moloud
Abdan, Mohsen
Ramezanpour, Melina
Dehkordi, Ali Hasanpour
Sarikhani, Diana
author_facet Fakhri, Moloud
Abdan, Mohsen
Ramezanpour, Melina
Dehkordi, Ali Hasanpour
Sarikhani, Diana
author_sort Fakhri, Moloud
collection PubMed
description BACKGROUND: Diabetes is the fifth leading cause of death in the world, which reduces the patients' quality of life (QOL) and is considered as an important subject especially in medicine and medical community. The present study aimed at investigating the QOL of diabetic patients in Iran through meta-analysis. METHODS: The search was conducted using relevant keywords in national and international databases including Iranmedex, SID, Magiran, IranDoc, Medlib, Science Direct, PubMed, Scopus, Cochrane, Embase, Web of Science. Questionnaires WHOQOL, SF-36, SF-20, DQOL, QOL, PedsQL, ADDQOL, D-39, DQOL-BCI, SWED-QUAL, IRDQOL, PHG-2, EQ-5D, and IDQOL-BCI were used to assess the QOL. Heterogeneity of studies was assessed using I(2) index. Data were analyzed using STATA version 11. RESULTS: In 96 studies of 17,994 people, the mean score of QOL in diabetic patients was based on the questionnaires WHOQOL [66.55 (95% CI: 45.83, 87.26)], D-39 [129.43 (95%CI: 88.77, 170.10)], SF-36 [65.64 (95% CI: 59.82, 71.46)], SF-20 [46.50 (95% CI: 37.19, 55.81], DQOL [61.19 (95% CI: 35.73, 86.66)], QOL [117.91 (95% CI: -62.97, 298.79)], PedsQL [34.36 (95% CI: -31.49, 100.22)], ADDQOL [41.76 (95% CI: 12.01-71.50)], SWED-QUAL [59.19 (95% CI: 21.15, 97.23)], IRDQOL [105.92 (95% CI: 102.73, 109.10)], PHG-2 [61.00 (95%CI: 59.63, 62.37)], EQ-5D [0.62 (95% CI: 0.61, 0.64)], DQOL-BCI [3.40 (95% CI: 3.31, 3.49)], and IDQOL-BCI [22.63 (95% CI: -2.38, 47.64)]. CONCLUSIONS: The QOL of diabetic patients was evaluated according to different types of questionnaires and the QOL of diabetic patients was found to be lower than normal population.
format Online
Article
Text
id pubmed-8223913
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-82239132021-06-30 Systematic Review and Meta-Analysis on Quality of Life in Diabetic Patients in Iran Fakhri, Moloud Abdan, Mohsen Ramezanpour, Melina Dehkordi, Ali Hasanpour Sarikhani, Diana Int J Prev Med Review Article BACKGROUND: Diabetes is the fifth leading cause of death in the world, which reduces the patients' quality of life (QOL) and is considered as an important subject especially in medicine and medical community. The present study aimed at investigating the QOL of diabetic patients in Iran through meta-analysis. METHODS: The search was conducted using relevant keywords in national and international databases including Iranmedex, SID, Magiran, IranDoc, Medlib, Science Direct, PubMed, Scopus, Cochrane, Embase, Web of Science. Questionnaires WHOQOL, SF-36, SF-20, DQOL, QOL, PedsQL, ADDQOL, D-39, DQOL-BCI, SWED-QUAL, IRDQOL, PHG-2, EQ-5D, and IDQOL-BCI were used to assess the QOL. Heterogeneity of studies was assessed using I(2) index. Data were analyzed using STATA version 11. RESULTS: In 96 studies of 17,994 people, the mean score of QOL in diabetic patients was based on the questionnaires WHOQOL [66.55 (95% CI: 45.83, 87.26)], D-39 [129.43 (95%CI: 88.77, 170.10)], SF-36 [65.64 (95% CI: 59.82, 71.46)], SF-20 [46.50 (95% CI: 37.19, 55.81], DQOL [61.19 (95% CI: 35.73, 86.66)], QOL [117.91 (95% CI: -62.97, 298.79)], PedsQL [34.36 (95% CI: -31.49, 100.22)], ADDQOL [41.76 (95% CI: 12.01-71.50)], SWED-QUAL [59.19 (95% CI: 21.15, 97.23)], IRDQOL [105.92 (95% CI: 102.73, 109.10)], PHG-2 [61.00 (95%CI: 59.63, 62.37)], EQ-5D [0.62 (95% CI: 0.61, 0.64)], DQOL-BCI [3.40 (95% CI: 3.31, 3.49)], and IDQOL-BCI [22.63 (95% CI: -2.38, 47.64)]. CONCLUSIONS: The QOL of diabetic patients was evaluated according to different types of questionnaires and the QOL of diabetic patients was found to be lower than normal population. Wolters Kluwer - Medknow 2021-05-15 /pmc/articles/PMC8223913/ /pubmed/34211672 http://dx.doi.org/10.4103/ijpvm.IJPVM_327_19 Text en Copyright: © 2021 International Journal of Preventive Medicine https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Review Article
Fakhri, Moloud
Abdan, Mohsen
Ramezanpour, Melina
Dehkordi, Ali Hasanpour
Sarikhani, Diana
Systematic Review and Meta-Analysis on Quality of Life in Diabetic Patients in Iran
title Systematic Review and Meta-Analysis on Quality of Life in Diabetic Patients in Iran
title_full Systematic Review and Meta-Analysis on Quality of Life in Diabetic Patients in Iran
title_fullStr Systematic Review and Meta-Analysis on Quality of Life in Diabetic Patients in Iran
title_full_unstemmed Systematic Review and Meta-Analysis on Quality of Life in Diabetic Patients in Iran
title_short Systematic Review and Meta-Analysis on Quality of Life in Diabetic Patients in Iran
title_sort systematic review and meta-analysis on quality of life in diabetic patients in iran
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223913/
https://www.ncbi.nlm.nih.gov/pubmed/34211672
http://dx.doi.org/10.4103/ijpvm.IJPVM_327_19
work_keys_str_mv AT fakhrimoloud systematicreviewandmetaanalysisonqualityoflifeindiabeticpatientsiniran
AT abdanmohsen systematicreviewandmetaanalysisonqualityoflifeindiabeticpatientsiniran
AT ramezanpourmelina systematicreviewandmetaanalysisonqualityoflifeindiabeticpatientsiniran
AT dehkordialihasanpour systematicreviewandmetaanalysisonqualityoflifeindiabeticpatientsiniran
AT sarikhanidiana systematicreviewandmetaanalysisonqualityoflifeindiabeticpatientsiniran